Exelixis (EXEL) Retained Earnings (2010 - 2026)

Exelixis' (EXEL) quarterly Retained Earnings came in at -$215.8 million in Q2 2026, down 10836.02% year-on-year from N/an in Q2 2025, and down 180.87% quarter-over-quarter from -$76.8 million in Q1 2026.

Exelixis (EXEL) Retained Earnings (2010 - 2026) Analysis & Trends

Exelixis' Retained Earnings history runs 17 years deep, the most recent figure standing at -$215.8 million for Q2 2026.

  • On a quarterly basis, Retained Earnings fell 10836.02% year-over-year to -$215.8 million in Q2 2026; TTM through Apr 2026 was -$215.8 million, a 10836.02% decrease from a year earlier, with the FY2026 full-year figure at -$76.8 million, up 22.12% from the prior year.
  • Retained Earnings retreated to -$215.8 million in Q2 2026 per EXEL's latest filing, from -$76.8 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $2.6 billion in Q1 2023 and bottomed at -$258.9 million in Q1 2024.
  • The 5-year median for Retained Earnings is $1.3 million (2025), against an average of $815.7 million.
  • Across the five-year window, Retained Earnings surged 61486.23% in 2023 and tumbled 10836.02% in 2026, its largest moves.
  • Year by year, Retained Earnings stood at -$14.5 million in 2022, then sank by 1093.8% to -$173.4 million in 2023, then soared by 1462.25% to $2.4 billion in 2024, then plunged by 99.85% to $3.6 million in 2025, then plunged by 6153.13% to -$215.8 million in 2026.
  • Per Business Quant, the three latest EXEL Retained Earnings figures stand at -$215.8 million (Q2 2026), -$76.8 million (Q1 2026), and $3.6 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -527.87 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -27.89 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 12.91 Bn
4 NuCana 279.75 Bn 279.75 Bn - 115.82 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 11.90 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -622,000.00
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn -215.79 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 -215.79 Mn
Jan 2, 2026 -76.83 Mn
Oct 3, 2025 3.57 Mn
Jul 4, 2025 1.35 Mn
Apr 4, 2025 2.01 Mn
Jan 3, 2025 -98.65 Mn
Sep 27, 2024 2.36 Bn
Jun 28, 2024 2.32 Bn
Mar 29, 2024 -258.95 Mn
Dec 29, 2023 -173.35 Mn
Sep 29, 2023 2.49 Bn
Jun 30, 2023 2.53 Bn
Mar 31, 2023 2.56 Bn
Dec 30, 2022 -14.52 Mn
Sep 30, 2022 -4.05 Mn
Jul 1, 2022 -8.92 Mn
Apr 1, 2022 2.45 Bn
Dec 31, 2021 -758,000.00
Oct 1, 2021 -311.67 Mn
Jul 2, 2021 -349.88 Mn